Publicacións en colaboración con investigadores/as de Instituto de Química Médica (11)

2024

  1. Periodic table screening for enhanced positive contrast in MRI and in vivo uptake in glioblastoma

    Chemical Science, Vol. 15, Núm. 22, pp. 8578-8590

  2. Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis

    Nanoscale, Vol. 16, Núm. 13, pp. 6477-6487

2023

  1. A Comparative Study of Ultrasmall Calcium Carbonate Nanoparticles for Targeting and Imaging Atherosclerotic Plaque

    ACS Nano, Vol. 17, Núm. 14, pp. 13811-13825

  2. Radiolabeled Iron Oxide Nanomaterials for Multimodal Nuclear Imaging and Positive Contrast Magnetic Resonance Imaging (MRI): A Review

    ACS Applied Nano Materials, Vol. 6, Núm. 22, pp. 20523-20538

2021

  1. Delayed alveolar clearance of nanoparticles through control of coating composition and interaction with lung surfactant protein A

    Materials Science and Engineering C

  2. Digitonin concentration is determinant for mitochondrial supercomplexes analysis by BlueNative page

    Biochimica et Biophysica Acta - Bioenergetics, Vol. 1862, Núm. 1

  3. HAP-Multitag, a PET and Positive MRI Contrast Nanotracer for the Longitudinal Characterization of Vascular Calcifications in Atherosclerosis

    ACS Applied Materials and Interfaces, Vol. 13, Núm. 38, pp. 45279-45290

2020

  1. Iron oxide nanoparticles: An alternative for positive contrast in magnetic resonance imaging

    Inorganics, Vol. 8, Núm. 4

  2. Thrombo-tag, an: In vivo formed nanotracer for the detection of thrombi in mice by fast pre-targeted molecular imaging

    Nanoscale, Vol. 12, Núm. 45, pp. 22978-22987

2019

  1. Cu-Doped Extremely Small Iron Oxide Nanoparticles with Large Longitudinal Relaxivity: One-Pot Synthesis and in Vivo Targeted Molecular Imaging

    ACS Omega, Vol. 4, Núm. 2, pp. 2719-2727

  2. Unambiguous detection of atherosclerosis using bioorthogonal nanomaterials

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 17, pp. 26-35